Predictors of safety and efficacy of 2-stage hepatectomy for bilateral colorectal liver metastases

Journal of the American College of Surgeons

Volumn 223, Issue 1, 2016, Pages 99-108

  Passot, Guillaume ^a   Chun, Yun Shin ^a   Kopetz, Scott E ^a   Zorzi, Daria ^a   Brudvik, Kristoffer Watten ^a   Kim, Bradford J ^a   Conrad, Claudius ^a   Aloia, Thomas A ^a   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLIZATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODAL IMAGING; OVERALL SURVIVAL; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; COLORECTAL TUMOR; FACTUAL DATABASE; GENETICS; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; ONCOGENE RAS; PATHOLOGY; PATIENT SAFETY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK FACTOR; SECONDARY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GENES, RAS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SAFETY; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84959934892     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2015.12.057     Document Type: Article

References (34)

1. R. Adam, A. Laurent, D. Azoulay, and et al. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors Ann Surg 232 2000 777 785
2. A. Brouquet, E.K. Abdalla, S. Kopetz, and et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome J Clin Oncol 29 2011 1083 1090
3. F. Faitot, O. Soubrane, D. Wendum, and et al. Feasibility and survival of 2-stage hepatectomy for colorectal metastases: definition of a simple and early clinicopathologic predicting score Surgery 157 2015 444 453
4. A. Muratore, G. Zimmitti, D. Ribero, and et al. Chemotherapy between the first and second stages of a two-stage hepatectomy for colorectal liver metastases: should we routinely recommend it? Ann Surg Oncol 19 2012 1310 1315
5. M. Narita, E. Oussoultzoglou, D. Jaeck, and et al. Two-stage hepatectomy for multiple bilobar colorectal liver metastases Br J Surg 98 2011 1463 1475
6. S. Tsai, H.P. Marques, M.C. de Jong, and et al. Two-stage strategy for patients with extensive bilateral colorectal liver metastases HPB (Oxford) 12 2010 262 269
7. O. Turrini, J. Ewald, F. Viret, and et al. Two-stage hepatectomy: who will not jump over the second hurdle? Eur J Surg Oncol 38 2012 266 273
8. D.A. Wicherts, R. Miller, R.J. de Haas, and et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases Ann Surg 248 2008 994 1005
9. A. Dupre, A. Lefranc, E. Buc, and et al. Use of bioresorbable membranes to reduce abdominal and perihepatic adhesions in 2-stage hepatectomy of liver metastases from colorectal cancer: results of a prospective, randomized controlled phase II trial Ann Surg 258 2013 30 36
10. G.A. Margonis, G. Spolverato, Y. Kim, and et al. Effect of KRAS mutation on long-term outcomes of patients undergoing hepatic resection for colorectal liver metastases Ann Surg Oncol 22 2015 4158 4165
11. G. Karagkounis, M.S. Torbenson, H.D. Daniel, and et al. Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases Cancer 119 2013 4137 4144
12. J.N. Vauthey, G. Zimmitti, S.E. Kopetz, and et al. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases Ann Surg 258 2013 619 626
13. S. Zakaria, J.H. Donohue, F.G. Que, and et al. Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 246 2007 183 191
14. L. Rubbia-Brandt, E. Giostra, C. Brezault, and et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery Ann Oncol 18 2007 299 304
15. D.G. Blazer 3rd, Y. Kishi, D.M. Maru, and et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 26 2008 5344 5351
16. Y. Kawamoto, K. Tsuchihara, T. Yoshino, and et al. KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer Br J Cancer 107 2012 340 344
17. K.W. Brudvik, S.E. Kopetz, L. Li, and et al. Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases Br J Surg 102 2015 1175 1183
18. Y. Kishi, E.K. Abdalla, Y.S. Chun, and et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry Ann Surg 250 2009 540 548
19. J. Shindoh, C.W. Tzeng, T.A. Aloia, and et al. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients J Gastrointest Surg 18 2014 45 51
20. S. Kopetz, and J.N. Vauthey Perioperative chemotherapy for resectable hepatic metastases Lancet 371 2008 963 965
21. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
22. J.T. Mullen, D. Ribero, S.K. Reddy, and et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy J Am Coll Surg 204 2007 854 862
23. A. Italiano, I. Hostein, I. Soubeyran, and et al. KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications Ann Surg Oncol 17 2010 1429 1434
24. N. Knijn, L.J. Mekenkamp, M. Klomp, and et al. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients Br J Cancer 104 2011 1020 1026
25. F. Giuliante, F. Ardito, A. Ferrero, and et al. Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients J Am Coll Surg 219 2014 285 294
26. J. Shindoh, E.M. Loyer, S. Kopetz, and et al. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases J Clin Oncol 30 2012 4566 4572
27. G. Torzilli, F. Procopio, F. Botea, and et al. One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach Surgery 146 2009 60 71
28. D. Elias, O. Baton, L. Sideris, and et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases J Surg Oncol 90 2005 36 42
29. A.A. Schnitzbauer, S.A. Lang, H. Goessmann, and et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings Ann Surg 255 2012 405 414
30. F. Faitot, M. Faron, R. Adam, and et al. Two-stage hepatectomy versus 1-stage resection combined with radiofrequency for bilobar colorectal metastases: a case-matched analysis of surgical and oncological outcomes Ann Surg 260 2014 822 827
31. T.A. Aloia, J.N. Vauthey, E.M. Loyer, and et al. Solitary colorectal liver metastasis: resection determines outcome Arch Surg 141 2006 460 466
32. H. Lee, J.S. Heo, Y.B. Cho, and et al. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: A propensity score analysis World J Gastroenterol 21 2015 3300 3307
33. E. Schadde, A.A. Schnitzbauer, C. Tschuor, and et al. Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy Ann Surg Oncol 22 2015 3109 3120
34. J. Shindoh, M.J. Truty, T.A. Aloia, and et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant J Am Coll Surg 216 2013 201 209